Novel treatment options of binge eating disorder

Current Medicinal Chemistry

Volumn 18, Issue 33, 2011, Pages 5159-5164

  Marazziti, D ^a   Rossi, L ^a   Baroni, S ^a   Consoli, G ^a   Hollander, E ^b   Catena Dell'Osso, M ^a  

^a UNIVERSITY OF PISA   (Italy)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Anticonvulsants; Binge eating Disorder; Eating Disorders; Ghrelin; Opiate Blockers; SNRI; Topiramate; Zonisamide

Indexed keywords

ANTICONVULSIVE AGENT; CHOLECYSTOKININ; CITALOPRAM; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; INSULIN; LEPTIN; NALMEFENE; NALOXONE; NALTREXONE; NEUROPEPTIDE Y1 RECEPTOR; NORADRENALIN UPTAKE INHIBITOR; OREXIN; PEPTIDE HORMONE; QUETIAPINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TOPIRAMATE; VENLAFAXINE; ZONISAMIDE;

APPETITE; ARTICLE; BINGE EATING DISORDER; BODY MASS; BODY WEIGHT; CALORIC INTAKE; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; FOOD INTAKE; HUMAN; HUNGER; HYPERSOMNIA; INSOMNIA; MEDLINE; METABOLISM; NUTRITIONAL COUNSELING; OBESITY; REMISSION; SATIETY; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION; XEROSTOMIA;

ANTICONVULSANTS; BINGE-EATING DISORDER; FRUCTOSE; GHRELIN; HUMANS; ISOXAZOLES; RECEPTORS, OPIOID; SEROTONIN UPTAKE INHIBITORS;

EID: 80054888653     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711797636045     Document Type: Article

References (68)

1. American Psychiatric Association Comitee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Ed. 4. American Psychiatric Press: Washington, DC, 1994.
2. Stunkard, A.J. Eating patterns and obesity. Psychiatr. Q., 1959, 33, 284-295.
3. Bruce, B.; Agras, W.S. Binge eating in females: A population-based investigation. Int. J. Eat. Disord., 2006, 12, 4, 365-373.
4. Kinzl, F.J.; Traweger, C.; Trefalt, E.; Mangweth, B.; Biebl, W. Binge eating in females: A population-based investigation. Int. J. Eat. Disord., 1999, 25, 3, 287-292. (Pubitemid 29153234)
5. Reba-Harrelson, L.; Von Holle, A.; Hamer, R.M.; Swann, R.; Reyes, M.L.; Bulik, C.M. Patterns and prevalence of disordered eating and weight control behaviors in women ages 25-45. Eat Weight Disord., 2009, 14, 4,190-198.
6. Smith, D.E.; Marcus, M.D.; Lewis, C.E.; Fitzgibbon, M.; Schreiner, P. Prevalence of binge eating disorder, obesity, and depression in biracial cohort of young adults. Ann. Behav. Med., 1998, 20, 3, 227-232 (Pubitemid 29072339)
7. Masheb, R.M.; Grilo, C.M. On the Relation of Attempting to Lose Weight, Restraint, and Binge Eating in Outpatients with Binge Eating Disorder. Obesity Research, 2000, 8, 638-645.
8. Díaz-Marsá, M.; Carrasco, J.L.; Basurte, E.; Sáiz, J.; López-Ibor, J.J., Hollander, E. Enhanced cortisol suppression in eating disorders with impulsive personality features. Psychiatry Res., 2008, 28, 158, 93-97.
9. Fernández-Aranda, F.; Pinheiro, A.P.; Thornton, L.M.; Berrettini, W.H.; Crow, S.; Fichter, M.M.; Halmi, K.A.; Kaplan, A.S.; Keel, P.; Mitchell, J.; Rotondo, A.; Strober, M.; Woodside, D.B.; Kaye, W.H.; Bulik, C.M. Impulse control disorders in women with eating disorders. Psychiatry Res., 2008, 15, 157, 147-157. (Pubitemid 350166546)
10. Alvarez-Moya, E.M.; Jiménez-Murcia, S.; Moragas, L.; Gómez-Peña, M.; Aymamí, M.N.; Ochoa, C.; Sánchez-Díaz, I.; Menchón, J.M.; Fernández- Aranda, F. Executive functioning among female pathological gambling and bulimia nervosa patients: Preliminary findings. J. Int. Neuropsychol. Soc., 2009, 15, 2, 302-306.
11. Beglin, S.J.; Fairburn, C.G. What is meant by the term "binge"? Am. J. Psychiatry, 1992, 149, 123-124.
12. Dell'Osso, B,, Altamura A.C., Allen, A., Marazziti, D., Hollander, E. Epidemiologic and clinical updates on impulse control disorders: A critical review. Eur. Arch. Psychiatry Clin. Neurosci., 2006, 256(8):464-475. (Pubitemid 46020521)
13. Reas, D.L.; Grilo, C.M. Review and meta-analysis of pharmacotherapy for binge-eating disorder. Obesity (Silver Spring), 2008, 16, 9, 2024-2038.
14. Brambilla, F.; Samek, L.; Company, M.; Lovo, F.; Cioni, L.; Mellado, C. Multivariate therapeutic approach to binge-eating disorder: Combined nutritional, psychological and pharmacological treatment. Int. Clin. Psychopharmacol., 2009, 24, 6, 312-317.
15. Leombruni, P.; Pierò, A.; Lavagnino, L.; Brustolin, A.; Campisi, S.; Fassino, S. A randomized, double-blind trial comparing sertraline and fluoxetine 6- month treatment in obese patients with Binge Eating Disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 1, 32, 1599-1605.
16. Green, R.S.; Rau, J.H. javascript:AL-get(this, 'jour', 'Am J Psychiatry.');Treatment of compulsive eating disturbances with anticonvulsant medication. Am. J. Psychiatry, 1974, 131, 428-432.
17. Moore, S.L.; Rakes, S.M. Binge eating - therapeutic response to diphenylhydantoin: Case report. J. Clin. Psychiatry, 1982, 43, 9, 385-386. (Pubitemid 12019219)
18. Pope, H.G.; Hudson, J.I. Antidepressant drug therapy for bulimia: Current status. J. Clin. Psychiatry, 1986, 47, 7, 339-345. (Pubitemid 16057601)
19. Appolinario, J.C.; McElroy, S.L. Pharmacological approaches in the treatment of binge eating disorder. Curr. Drug Targets, 2004, 5, 3, 301-307. (Pubitemid 38372314)
20. Tata, A.L.; Kockler, D.R. Topiramate for binge-eating disorder associated with obesity. Ann. Pharmacother., 2006, 40, 11, 1993-1997. (Pubitemid 44747469)
21. Wilfley, D.E.; Crow, S.J.; Hudson, J.I.; Mitchell, J.E.; Berkowitz, R.I.; Blakesley, V.; Walsh, B.T. Efficacy of sibutramine for the treatment of binge eating disorder: A randomized multicenter placebo-controlled double-blind study. Am. J. Psychiatry, 2008, 165, 1, 51-58. (Pubitemid 351704552)
22. Tziomalos, K.; Krassas, G.E.; Tzotzas, T. The use of sibutramine in the management of obesity and related disorders: An update. Vasc. Health Risk Manag., 2009, 5, 1, 441-452.
23. McElroy, S.L.; Kotwal, R.; Guerdjikova, A.I.;, Welge, J.A.; Nelson, E.B.; Lake, K.A.; D'Alessio, D.A.; Keck, P.E.; Hudson, J.I. Zonisamide in the treatment of binge eating disorder with obesity: A randomized controlled trial. J. Clin. Psychiatry, 2006, 67, 12, 1897-1906. (Pubitemid 46055195)
24. Leombruni, P.; Lavagnino, L.; Fassino, S. Treatment of obese patients with binge eating disorder using topiramate: A review. Neuropsychiatr. Dis. Treat., 2009, 5, 385-392.
25. Nicolato, R.; Romano-Silva, M.A.; Correa, H.; Salgado, J.V.; Teixeira, A.L. Lithium and topiramate association in the treatment of comorbid pathological gambling and bipolar disorder. Aust. N. Z. J. Psychiatry, 2007, 41, 7, 628.
26. Arbaizar, B.; Gómez-Acebo, I.; Llorca, J. Efficacy of topiramate in bulimia nervosa and binge-eating disorder: A systematic review. Gen. Hosp. Psychiatry, 2008, 30, 5, 471-475.
27. Correll, C.U.; Sheridan, E.M.; DelBello, M.P. Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: A comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord., 2010, 12, 2, 116-141.
28. Ortiz, A.; Alda, M. Treatment of bipolar disorder with comorbid migraine. J. Psychiatry Neurosci., 2010, 35, 1, E1-2.
29. Stanley, B.G.; Willett, V.L.3rd; Donias, H.W.; Dee, M.G.2nd; Duva, M.A. Lateral hypothalamic NMDA receptors and glutamate as physiological mediators of eating and weight control. Am. J. Physiol., 1996, 270, R443- 449.
30. Shapira, N.A.; Goldsmith, T.D.; McElroy, S.L. Treatment of binge-eating disorder with topiramate: A clinical case series. J. Clin. Psychiatry, 2000, 61, 5, 368-372. (Pubitemid 30345939)
31. Appolinario, J.C.; Fontenelle, L.F.; Papelbaum, M.; Bueno, J.R.; Coutinho, W. Topiramate use in obese patients with binge eating disorder: An open study. Can. J. Psychiatry, 2002, 47, 3, 271-273. (Pubitemid 34614686)
32. McElroy, S.L.; Arnold, L.M.; Shapira, N.A.; Keck, P.E.Jr; Rosenthal, N.R.; Karim, M.R.; Kamin, M.; Hudson, J.I. Topiramate in the treatment of binge eating disorder associated with obesity: A randomized, placebo-controlled trial. Am. J. Psychiatry, 2003, 160, 2, 255-261. (Pubitemid 41110450)
33. Appolinario, J.C.; Coutinho, W.; Fontanelle, L. Topiramate for binge eating disorder. Am. J. Psychiatry, 2001, 158, 967-968.
34. De Bernardi, C.; Ferraris, S.; D'Innella, P.; Do, F.; Torre, E. Topiramate for binge eating disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2005, 29, 339-341. (Pubitemid 40202922)
35. Chengappa, K.N.; Rathore, D.; Levine, J.; Atzert, R.; Solai, L.; Parepally, H.; Levin, H.; Moffa, N.; Delaney, J.; Brar, J.S. Topiramate as add-on treatment for patients with bipolar mania. Bipolar Disord., 1999, 1, 1, 42-53.
36. Barbee, J.G. Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: A case series. Int. J. Eat. Disord., 2003, 33, 4, 468-472. (Pubitemid 36397437)
37. Zilberstein, B.; Pajecki, D.; de Brito, A.C.G.; Gallafrio, S.T.; Eshkenazy, R.; Andrade, C.G. Topiramate after Adjustable Gastric Banding in Patients with Binge Eating and Difficulty Losing Weight. Obes. Surg., 2004, 14, 6.
38. Guerdjikova, A.I.; Kotwal, R.; McElroy, S.L. Response of recurrent binge eating and weight gain to topiramate in patients with binge eating disorder after bariatric surgery. Obes. Surg., 2005, 15, 2, 273-277. (Pubitemid 40316016)
39. Zaccara, G.; Specchio, L.M. Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: A review of the literature. Neuropsychiatr. Dis. Treat., 2009, 5, 249-259.
40. Malhotra, S.; King, K.H.; Welge, J.A.; Brusman-Lovins, L.; McElroy, S.L. Venlafaxine treatment of binge-eating disorder associated with obesity: A series of 35 patients. J. Clin. Psychiatry, 2002, 63, 9, 802-806.
41. Hazen, E.; Fava, M. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: A case report. J. of Psychopharmacology, 2006, 20, 5, 723-724. (Pubitemid 44315873)
42. Leombruni, P.; Lavagnino, L.; Gastaldi, F.; Vasile. A.; Fassino, S. Duloxetine in obese binge eater outpatients: Preliminary results from a 12- week open trial. Hum. Psychopharmacol., 2009, 24, 6, 483-488.
43. Heal, D.J.; Aspley, S.; Prow, M.R.; Jackson, H.C.; Martin, K.F.; Cheetham, S.C. Sibutramine: A novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine. Int. J. Obes. Relat. Metab. Disord., 1998, 22, 1, S18-29. (Pubitemid 28393745)
44. Appolinario, J.C.; Godoy-Matos, A.; Fontenelle, L.F.; Carraro, L.; Cabral, M.; Vieira, A.; Coutinho, W. An open-label trial of sibutramine in obese patients with binge-eating disorder. J. Clin. Psychiatry, 2002, 63, 1, 28-30. (Pubitemid 34113483)
45. Appolinario, J.C.; Bacaltchuk, J.; Sichieri, R.; Claudino, A.M.; Godoy- Matos, A.; Morgan, C.; Zanella, M.T.; Coutinho, W. A randomized, doubleblind, placebo-controlled study of sibutramine in the treatment of bingeeating disorder. Arch. Gen. Psychiatry, 2003, 60, 11, 1109-1116. (Pubitemid 37429650)
46. Milano, W.; Petrella, C.; Casella, A.; Capasso, A.; Carrino, S.; Milano, L. Use of sibutramine an inhibitor of the reuptake of serotonin and noradrenaline, in the treatment of binge eating disorder: A placebo-controlled study. Advances in Therapy, 2005, 22, 1.
47. Bauer, C.; Fischer, A.; Keller, U. Effect of sibutramine and of cognitivebehavioural weight loss therapy in obesity and subclinical binge eating disorder. Diabetes Obes. Metab., 2006, 8, 3, 289-295.
48. Jain, R.; Mukherjee, K.; Singh, R. Influence of sweet tasting solutions on opioid withdrawal. Brain Res. Bull., 2004, 15, 64, 4, 319-322. (Pubitemid 39550767)
49. Erlanson-Albertsson, C. Sugar triggers our reward-system. Sweets release opiates which stimulates the appetite for sucrose-insulin can depress it. Lakartidningen, 2005, 102, 1620-1627.
50. Marrazzi, M.A.; Markham, K.M.; Kinzie, J.; Luby, E.D. Binge eating disorder: Response to naltrexone. Int. J. Obes. Relat. Metab. Disord., 1995, 19, 143-145.
51. Fantino, M.; Hosotte, J.; Apfelbaum, M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am. J. Physiol., 1986, 251, R91- 96.
52. Taha, S.A.; Norsted, E.; Lee, L.S.; Lang, P.D.; Lee, B.S.; Woolley, J.D.; Fields, H.L. Endogenous opioids encode relative taste preference. Eur. J. Neurosci., 2006, 24, 4, 1220-1226. (Pubitemid 44268152)
53. Richardson, D.K.; Reynolds, S.M.; Cooper, S.J.; Berridge, K.C. Endogenous opioids are necessary for benzodiazepine palatability enhancement: Naltrexone blocks diazepam-induced increase of sucrose-'liking'. Pharmacol. Biochem. Behav., 2005, 81, 3, 657-663. (Pubitemid 40966813)
54. Yeomans, M.R.; Wright, P. Lower pleasantness of palatable foods in nalmefene-treated human volunteers. Appetite, 1991, 16, 3, 249-259.
55. Avena, N.M. Examining the addictive-like properties of binge eating using an animal model of sugar dependence. Exp. Clin. Psychopharmacol., 2007, 15, 5, 481-491. (Pubitemid 350102235)
56. Drewnowski, A.; Krahn, D.D.; Demitrack, M.A.; Nairn, K.; Gosnell, B.A. Naloxone, an opiate blocker, reduces the consumption of sweet high-fat foods in obese and lean female binge eaters. Am. J. Clin. Nutr., 1995, 61, 6, 1206-1212.
57. Neumeister, A.; Winkler, A.; Wöber-Bingöl, C. Addition of naltrexone to fluoxetine in the treatment of binge eating disorder. Am. J. Psychiatry, 1999, 156, 5, 797. (Pubitemid 29220087)
58. Chen, C.Y.; Asakawa, A.; Fujimiya, M.; Lee, S.D.; Inui, A. Ghrelin gene products and the regulation of food intake and gut motility. Pharmacol. Rev., 2009, 61, 4, 430-481.
59. Kageyama, H.; Takenoya, F.; Shiba, K.; Shioda, S. Neuronal circuits involving ghrelin in the hypothalamus-mediated regulation of feeding. Neuropeptides, 2010, 44, 2, 133-138.
60. Snoek, S.A.; Borensztajn, K.S.; van den Wijngaard, R.M.; de Jonge, W.J. Neuropeptide receptors in intestinal disease: Physiology and therapeutic potential. Curr. Pharm. Des., 2010, 16, 9, 1091-1105.
61. Tanaka, M.; Naruo, T.; Muranaga, T.; Yasuhara, D.; Shiiya, T.; Nakazato, M.; Matsukura, S.; Nozoe, S. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. European Journal of Endocrinology, 2002, 146, 6, 1-3.
62. Otto, B.; Spranger, J.; Benoit, S.C.; Clegg, D.J.; Tschöp, M.H. The many faces of ghrelin: New perspectives for nutrition research? Br. J. Nutr., 2005, 93, 6, 765-771. (Pubitemid 43899552)
63. Monteleone, P.; Castaldo, E.; Maj, M. Neuroendocrine dysregulation of food intake in eating disorders. Regul. Pept., 2008, 7, 149, 39-50.
64. Geliebter, A.; Gluck, M.E.; Hashim, S.A. Plasma Ghrelin Concentrations Are Lower in Binge-Eating Disorder Journal Nutrition, 2005, 135, 1326-1330. (Pubitemid 40638358)
65. Ukkola, O.; Ravussin, E.; Jacobson, P.; Pérusse, L.; Rankinen, T.; Tschöp, M.; Heiman, M.L.; Leon, A.S.; Rao, D.C.; Skinner, J.S.; Wilmore, J.H.; Sjöström, L.; Bouchard, C. Role of ghrelin polymorphisms in obesity based on three different studies. Obes. Res., 2002, 10, 8, 782-791. (Pubitemid 135687519)
66. Hinney, A.; Hoch, A.; Geller, F.; Schäfer, H.; Siegfried, W.; Goldschmidt, H.; Remschmidt, H.; Hebebrand, J. Ghrelin gene: Identification of missense variants and a frameshift mutation in extremely obese children and adolescents and healthy normal weight students. J. Clin. Endocrinol. Metab., 2002, 87, 6, 2716.
67. Miyasaka, K.; Hosoya, H.; Sekime, A.; Ohta, M.; Amono, H.; Matsushita, S.; Suzuki, K.; Higuchi, S.; Funakoshi, A. Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population. J. Neural Transm., 2006, 113, 9, 1279-1285. (Pubitemid 44291021)
68. Gueorguiev, M.; Lecoeur, C.; Meyre, D.; Benzinou, M.; Mein, C.A.; Hinney, A.; Vatin, V.; Weill, J.; Heude, B.; Hebebrand, J.; Grossman, A.B.; Korbonits, M.; Froguel, P. Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity. Obesity, 2009, 17, 4, 745-754.